Developing World Bioethics 8 (2):82-88 (2008)
|Abstract||This paper discusses the link between pharmacogenetics and race, and the global justice issues that the introduction of pharmacogenetics in pharmaceutical research and clinical practice will raise. First, it briefly outlines the likely impact of pharmacogenetics on pharmaceutical research and clinical practice within the next five to ten years and then explores the link between pharmacogenetic traits and 'race'. It is shown that any link between apparent race and pharmacogenetics is problematic and that race cannot be used as a proxy for pharmacogenetic knowledge. The final section considers the implications of the development of pharmacogenetics for health care systems in low- and middle-income countries.|
|Keywords||No keywords specified (fix it)|
|Through your library||Configure|
Similar books and articles
Richard E. Ashcroft & Adam M. Hedgecoe (2006). Genetic Databases and Pharmacogenetics: Introduction. Studies in History and Philosophy of Science Part C 37 (3):499-502.
Paul C. Taylor (2004). Race: A Philosophical Introduction. Distributed in the Usa by Blackwell Pub..
O. P. Corrigan (2005). Pharmacogenetics, Ethical Issues: Review of the Nuffield Council on Bioethics Report. [REVIEW] Journal of Medical Ethics 31 (3):144-148.
Lilian Schubert (2004). Ethical Implications of Pharmacogenetics – Do Slippery Slope Arguments Matter? Bioethics 18 (4):361–378.
Lisa Gannett (2005). Group Categories in Pharmacogenetics Research. Philosophy of Science 72 (5):1232-1247.
Michael Root (2003). The Use of Race in Medicine as a Proxy for Genetic Differences. Philosophy of Science 70 (5):1173-1183.
Allen E. Buchanan, Andrea Califano, Jeffrey Kahn, Elizabeth McPherson, John A. Robertson & Baruch A. Brody (2002). Pharmacogenetics: Ethical Issues and Policy Options. Kennedy Institute of Ethics Journal 12 (1):1-15.
Added to index2009-01-28
Total downloads6 ( #145,498 of 549,037 )
Recent downloads (6 months)1 ( #63,261 of 549,037 )
How can I increase my downloads?